NEXT GENERATION SEQUENCING MARKET ​.pptx

The global next generation sequencing market was valued at $13 billion in 2023, and is projected to reach $97.8 billion by 2035, growing at a CAGR of 18.3% from 2024 to 2035.

1. Next Generation Sequencing Market North America is expected to maintain its domiance by 2035.

2. Prime determinants of growth Growth in adoption of next generation sequencing, advancements in technologies and presence of key players are the factors that drive the growth of the global next generation sequencing market. However, complexity in data analysis and interpretation, requiring skilled bioinformatics expertise is anticipated to hinder market growth. On the contrary, a rise in healthcare expansion is expected to offer remunerative opportunities for the next generation sequencing market during the forecast period. According to the report, the  global next generation sequencing market  was valued at $13 billion in 2023 and is estimated to reach  $97.8 billion by 2035 , exhibiting a CAGR of 18.3% from 2024 to 2035.

3. Key Features of NGS: Parallelism : NGS sequences millions of fragments simultaneously. High Throughput : Capable of sequencing entire genomes quickly. Cost-Effective : Lower cost per base compared to Sanger sequencing. Versatile : Can sequence DNA, RNA, and epigenetic modifications.

4. How Does NGS Work? Library Preparation : DNA or RNA is fragmented and tagged with adapters to create a library of fragments. Amplification : The library is amplified to increase the amount of DNA for sequencing. Sequencing : The amplified library is sequenced using platforms like Illumina, Oxford Nanopore, or PacBio. These platforms differ in their sequencing techniques but all provide high-throughput data. Data Analysis : Bioinformatics tools are used to assemble the sequence reads, align them to a reference genome, and identify genetic variations.

5. Leading Market Players: Illumina Inc. F. Hoffmann-La Roche AG Qiagen N.V ABGI group PerkinElmer, Inc Agilent Technologies, Inc. Pacific Biosciences of California Thermo Fisher Scientific Inc. Precigen Inc

6. The sequencing by synthesis segment to maintain its lead position during the forecast period. By technology, the sequencing by synthesis segment accounted for the largest share in 2023, accounting for two-thirds of the global next generation sequencing market revenue. This is attributed to its efficiency in generating high-quality sequencing data at scale, meeting the increasing demand for rapid and economic genomic analysis in diverse applications. Connect to our Analyst-  https://www.alliedmarketresearch.com/connect-to-analyst/2048